TScan Therapeutics
Marlyane Motta is a seasoned professional in clinical operations with extensive experience in the biopharmaceutical industry. Currently serving as Senior Director of Clinical Operations at TScan Therapeutics since December 2022, Marlyane previously held pivotal roles at Repertoire Immune Medicines as Director and Associate Director of Clinical Operations from January 2019 to November 2022. Prior experience includes a position as Clinical Research Manager at Merck and Clinical Trial Leader at Novartis Institutes for BioMedical Research, along with various roles in clinical research and coordination at Millennium Pharmaceuticals, EMD - Affiliates of Merck KGaA, and PAREXEL. Marlyane Motta holds a degree in Biology and Political Science from UMass Boston, completed between 1998 and 2003.